PATENTS RELATED TO VACCINES

Professor Demchick's Patent Services

Paul H. Demchick, United States Registered Patent Agent
(United States Patent and Trademark Office Registration 52,808)

PATENTS RELATED TO VACCINES

Although Dr. Demchick also represents patent seekers with non-microbiological inventions, his doctorate is in microbiology. Microbiology has been the primary focus of his research and teaching. He especially loves dealing with patent searches and applications for involving microbiology.

Dr. Demchick is a scientist with a quarter of a century of research experience in academic, industrial and governmental settings.
If you are considering patent protection for an invention, Dr. Demchick will be glad to discuss the matter with you. There is no charge for an initial discussion.
The following sampling is to give you some sense of the types of vaccines related inventions which have received United States patent protection. The patent list is not exhaustive and is certainly not a substitute for a proper patent search . It should be noted that only U.S. Patents are included.
It should be noted that spelling, form and typographical errors in the original patents are preserved here.

West nile vaccine (United States Patent 7,153,513)
Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine (United States Patent 7,153,511)
Vaccine immunotherapy for immune suppressed patients (United States Patent 7,153,499)
Attenuated vif DNA immunization cassettes for genetic vaccines (United States Patent 7,151,172)
Attenuated human rotavirus vaccine (United States Patent 7,150,984)
Preventives/remedies for infection, anti-endtoxin agents, vaccine adjuvants and growth promoters (United States Patent 7,150,885)
Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine (United States Patent 7,150,875)
Coccidiosis vaccines (United States Patent 7,150,873)
Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus (United States Patent 7,148,323)
Vaccine composition containing adjuvants (United States Patent 7,147,862)
Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate (United States Patent 7,147,861)
Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof (United States Patent 7,144,712)
M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever (United States Patent 7,144,580)
Helicobacter pylori proteins useful for vaccines and diagnostics (United States Patent 7,141,244)
Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP) (United States Patent 7,138,274)
Urogenital or anorectal transmucosal vaccine delivery system (United States Patent 7,135,191)
DNA vaccine containing tumor-associated gene and cytokine gene and method of preparation the same (United States Patent 7,132,407)
Methods for enhancing the production of viral vaccines in cell culture (United States Patent 7,132,271)
Streptococcus pneumoniae proteins and vaccines (United States Patent 7,132,107)
Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof (United States Patent 7,128,919)
Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines (United States Patent 7,128,917)
Membrane virus host range mutations and their uses as vaccine substrates (United States Patent 7,128,915)
Streptococcus suis vaccines and diagnostic tests (United States Patent 7,125,548)
Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs (United States Patent 7,122,194)
Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis (United States Patent 7,122,193)
Porcine circoviruses, vaccines and diagnostic reagents (United States Patent 7,122,192)
Microfluidized oil-in-water emulsions and vaccine compositions (United States Patent 7,122,191)
Live genetically attenuated malaria vaccine (United States Patent 7,122,179)
Gene expression vaccine (United States Patent 7,118,888)
Transformed bacteria producing CS6 antigens as vaccines (United States Patent 7,118,758)
Meningococcal class 1 outer-membrane protein vaccine (United States Patent 7,118,757)
DNA vaccines encoding antigen linked to a domain that binds CD40 (United States Patent 7,118,751)
Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA (United States Patent 7,118,750)
Multi-mutant diphtheria toxin vaccines (United States Patent 7,115,725)
Smallpox vaccine (United States Patent 7,115,270)
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides (United States Patent 7,112,332)
Vaccines against varicella zoster virus gene 63 product (United States Patent 7,112,331)
Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment (United States Patent 7,109,026)
Viral vectors and viral vaccines based on recombinant porcine adenoviruses (United States Patent 7,109,025)
Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines (United States Patent 7,105,574)
Conjugate vaccines for the prevention of dental caries (United States Patent 7,101,562)
Combination vaccine for administration to adolescents (United States Patent 7,101,560)
High yield pertussis vaccine production strain and method for making same (United States Patent 7,101,558)
Mycobacterial proteins, microorganisms producing them and their use for vaccines and the detection of tuberculosis (United States Patent 7,101,555)
Picornaviruses, vaccines and diagnostic kits (United States Patent 7,101,554)
Modified vaccinia virus ankara for the vaccination of neonates (United States Patent 7,097,842)
Ferritin fusion proteins for use in vaccines and other applications (United States Patent 7,097,841)
Synthetic vaccine agents (United States Patent 7,097,837)
Polynucleotide herpes virus vaccine (United States Patent 7,094,767)
Development of a preventive vaccine for filovirus infection in primates (United States Patent 7,094,598)
Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis (United States Patent 7,094,597)
DNA vaccine against proliferating endothelial cells and methods of use thereof (United States Patent 7,094,410)
Immunogenicity using a combination of DNA and vaccinia virus vector vaccines (United States Patent 7,094,408)
Babesia canis vaccine (United States Patent 7,090,849)
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof (United States Patent 7,087,236)
Recombinant multivalent viral vaccine (United States Patent 7,087,234)
Self antigen vaccines for treating B cell lymphomas and other cancers (United States Patent 7,084,256)
Tumor associated antigen peptides and use of same as anti-tumor vaccines (United States Patent 7,084,249)
Inactivated respiratory syncytial viral vaccines (United States Patent 7,083,795)
Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype (United States Patent 7,083,794)
Yeast-dendritic cell vaccines and uses thereof (United States Patent 7,083,787)
Recombinant vaccine against botulinum neurotoxin (United States Patent 7,081,529)
Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 (United States Patent 7,081,342)
Neisserial vaccine compositions and methods (United States Patent 7,081,244)
DNA vaccines for farm animals, in particular bovines and porcines (United States Patent 7,078,388)
Anti-amoebic vaccine (United States Patent 7,078,044)
Malaria vaccine (United States Patent 7,078,043)
Method of DNA vaccination (United States Patent 7,074,770)
Antigen of hybrid M protein and carrier for group A streptococcal vaccine (United States Patent 7,074,416)
Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife (United States Patent 7,074,413)
Modified HCV peptide vaccines (United States Patent 7,074,410)
Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines (United States Patent 7,070,790)
Recombinant Newcastle disease virus nucleoprotein mutant as a marker vaccine (United States Patent 7,070,789)
Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis (United States Patent 7,067,138)
HIV vaccine (United States Patent 7,067,134)
Modified live Edwardsiella tarda vaccine for aquatic animals (United States Patent 7,067,122)
Use of HIV-1 gp120 and gp160 proteins modified in the v3 loop for the preparation of vaccine compositions and formulations containing the same (United States Patent 7,063,849)
Live vaccines for allergy treatment (United States Patent 7,060,687)
Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins (United States Patent 7,060,277)
Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines (United States Patent 7,056,510)
Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle (United States Patent 7,056,492)
Inactivated influenza virus vaccine for nasal or oral application (United States Patent 7,052,701)
Vaccinia virus MVA-E3L-knockout-mutants and use thereof (United States Patent 7,049,145)
Method of vaccination comprising linear and circular expression elements (United States Patent 7,049,098)
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA (United States Patent 7,045,313)
Salmonella vaccine (United States Patent 7,045,122)
Peptides for vaccinating against human CMV (United States Patent 7,041,442)
Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines (United States Patent 7,041,300)
Escape mutants of newcastle disease virus as marker vaccines (United States Patent 7,041,299)
Vaccine-induced hepatitis B viral strain and uses thereof (United States Patent 7,038,035)
Method for generating influenza viruses and vaccines (United States Patent 7,037,707)
Pestivirus mutants and vaccines containing the same (United States Patent 7,037,508)
Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry (United States Patent 7,037,506)
Methods and apparatus for harvesting vaccine from eggs (United States Patent 7,034,926)
Inactivated vaccines for aids and other infectious diseases (United States Patent 7,033,813)
DNA vaccination for treatment of autoimmune disease (United States Patent 7,030,098)
Inactivated vaccine against feline calicivirosis (United States Patent 7,029,682)
Multiple and multivalent DNA vaccines in ovo (United States Patent 7,029,681)
Vaccines (United States Patent 7,029,678)
EIA vaccine and diagnostic (United States Patent 7,026,113)
West nile vaccine (United States Patent 7,153,513)
Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine (United States Patent 7,153,511)
Vaccine immunotherapy for immune suppressed patients (United States Patent 7,153,499)
Attenuated vif DNA immunization cassettes for genetic vaccines (United States Patent 7,151,172)
Attenuated human rotavirus vaccine (United States Patent 7,150,984)
Preventives/remedies for infection, anti-endtoxin agents, vaccine adjuvants and growth promoters (United States Patent 7,150,885)
Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine (United States Patent 7,150,875)
Coccidiosis vaccines (United States Patent 7,150,873)
Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus (United States Patent 7,148,323)
Vaccine composition containing adjuvants (United States Patent 7,147,862)
Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate (United States Patent 7,147,861)
Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof (United States Patent 7,144,712)
M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever (United States Patent 7,144,580)
Helicobacter pylori proteins useful for vaccines and diagnostics (United States Patent 7,141,244)
Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP) (United States Patent 7,138,274)
Urogenital or anorectal transmucosal vaccine delivery system (United States Patent 7,135,191)
DNA vaccine containing tumor-associated gene and cytokine gene and method of preparation the same (United States Patent 7,132,407)
Methods for enhancing the production of viral vaccines in cell culture (United States Patent 7,132,271)
Streptococcus pneumoniae proteins and vaccines (United States Patent 7,132,107)
Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof (United States Patent 7,128,919)
Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines (United States Patent 7,128,917)
Membrane virus host range mutations and their uses as vaccine substrates (United States Patent 7,128,915)
Streptococcus suis vaccines and diagnostic tests (United States Patent 7,125,548)
Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural motifs (United States Patent 7,122,194)
Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis (United States Patent 7,122,193)
Porcine circoviruses, vaccines and diagnostic reagents (United States Patent 7,122,192)
Microfluidized oil-in-water emulsions and vaccine compositions (United States Patent 7,122,191)
Live genetically attenuated malaria vaccine (United States Patent 7,122,179)
Gene expression vaccine (United States Patent 7,118,888)
Transformed bacteria producing CS6 antigens as vaccines (United States Patent 7,118,758)
Meningococcal class 1 outer-membrane protein vaccine (United States Patent 7,118,757)
DNA vaccines encoding antigen linked to a domain that binds CD40 (United States Patent 7,118,751)
Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA (United States Patent 7,118,750)
Multi-mutant diphtheria toxin vaccines (United States Patent 7,115,725)
Smallpox vaccine (United States Patent 7,115,270)
Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides (United States Patent 7,112,332)
Vaccines against varicella zoster virus gene 63 product (United States Patent 7,112,331)
Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment (United States Patent 7,109,026)
Viral vectors and viral vaccines based on recombinant porcine adenoviruses (United States Patent 7,109,025)
Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines (United States Patent 7,105,574)
Conjugate vaccines for the prevention of dental caries (United States Patent 7,101,562)
Combination vaccine for administration to adolescents (United States Patent 7,101,560)
High yield pertussis vaccine production strain and method for making same (United States Patent 7,101,558)
Mycobacterial proteins, microorganisms producing them and their use for vaccines and the detection of tuberculosis (United States Patent 7,101,555)
Picornaviruses, vaccines and diagnostic kits (United States Patent 7,101,554)
Modified vaccinia virus ankara for the vaccination of neonates (United States Patent 7,097,842)
Ferritin fusion proteins for use in vaccines and other applications (United States Patent 7,097,841)
Synthetic vaccine agents (United States Patent 7,097,837)
Polynucleotide herpes virus vaccine (United States Patent 7,094,767)
Development of a preventive vaccine for filovirus infection in primates (United States Patent 7,094,598)
Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis (United States Patent 7,094,597)
DNA vaccine against proliferating endothelial cells and methods of use thereof (United States Patent 7,094,410)
Immunogenicity using a combination of DNA and vaccinia virus vector vaccines (United States Patent 7,094,408)
Babesia canis vaccine (United States Patent 7,090,849)
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof (United States Patent 7,087,236)
Recombinant multivalent viral vaccine (United States Patent 7,087,234)
Self antigen vaccines for treating B cell lymphomas and other cancers (United States Patent 7,084,256)
Tumor associated antigen peptides and use of same as anti-tumor vaccines (United States Patent 7,084,249)
Inactivated respiratory syncytial viral vaccines (United States Patent 7,083,795)
Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype (United States Patent 7,083,794)
Yeast-dendritic cell vaccines and uses thereof (United States Patent 7,083,787)
Recombinant vaccine against botulinum neurotoxin (United States Patent 7,081,529)
Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 (United States Patent 7,081,342)
Neisserial vaccine compositions and methods (United States Patent 7,081,244)
DNA vaccines for farm animals, in particular bovines and porcines (United States Patent 7,078,388)
Anti-amoebic vaccine (United States Patent 7,078,044)
Malaria vaccine (United States Patent 7,078,043)
Method of DNA vaccination (United States Patent 7,074,770)
Antigen of hybrid M protein and carrier for group A streptococcal vaccine (United States Patent 7,074,416)
Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife (United States Patent 7,074,413)
Modified HCV peptide vaccines (United States Patent 7,074,410)
Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines (United States Patent 7,070,790)
Recombinant Newcastle disease virus nucleoprotein mutant as a marker vaccine (United States Patent 7,070,789)
Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis (United States Patent 7,067,138)
HIV vaccine (United States Patent 7,067,134)
Modified live Edwardsiella tarda vaccine for aquatic animals (United States Patent 7,067,122)
Use of HIV-1 gp120 and gp160 proteins modified in the v3 loop for the preparation of vaccine compositions and formulations containing the same (United States Patent 7,063,849)
Live vaccines for allergy treatment (United States Patent 7,060,687)
Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins (United States Patent 7,060,277)
Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines (United States Patent 7,056,510)
Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle (United States Patent 7,056,492)
Inactivated influenza virus vaccine for nasal or oral application (United States Patent 7,052,701)
Vaccinia virus MVA-E3L-knockout-mutants and use thereof (United States Patent 7,049,145)
Method of vaccination comprising linear and circular expression elements (United States Patent 7,049,098)
Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA (United States Patent 7,045,313)
Salmonella vaccine (United States Patent 7,045,122)
Peptides for vaccinating against human CMV (United States Patent 7,041,442)
Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines (United States Patent 7,041,300)
Escape mutants of newcastle disease virus as marker vaccines (United States Patent 7,041,299)
Vaccine-induced hepatitis B viral strain and uses thereof (United States Patent 7,038,035)
Method for generating influenza viruses and vaccines (United States Patent 7,037,707)
Pestivirus mutants and vaccines containing the same (United States Patent 7,037,508)
Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry (United States Patent 7,037,506)
Methods and apparatus for harvesting vaccine from eggs (United States Patent 7,034,926)
Inactivated vaccines for aids and other infectious diseases (United States Patent 7,033,813)
DNA vaccination for treatment of autoimmune disease (United States Patent 7,030,098)
Inactivated vaccine against feline calicivirosis (United States Patent 7,029,682)
Multiple and multivalent DNA vaccines in ovo (United States Patent 7,029,681)
Vaccines (United States Patent 7,029,678)
EIA vaccine and diagnostic (United States Patent 7,026,113)

Although his recognition as a registered patent agent permits him to represent others in all patent matters before the United States Patent and Trademark Office, Dr. Demchick limits his practice to patent matters involving inventions for which he is confident that his expertise will allow him to serve his client well. He will gladly discuss whether he is comfortable handling cases involving inventions in a particular field. He will err on the side of declining cases if he has uncertainty about his ability to do what is needed in the case. Dr. Demchick does not represent clients in court. However, he refers clients to a patent attorney who does represent others in court, if it appears likely that patent related representation in court is appropriate. Dr. Demchick prepares and files non-provisional (regular) patent applications and provisional patent applications. He prepares and files utility patent applications and design patent applications. He prepares and files U.S. patent applications and international patent applications under the Patent Cooperation Treaty (PCT). He prepares and files applications to enter the U.S. National Phase for inventions for which international patent applications (PCT) were already filed. One of the matters he discusses with each client or potential client is which type of application(s) best meets that client's needs. He usually does a patent search (patentability search) as part of the preparation of a patent application. He discusses the value of patent searching with each inventor before agreeing to prepare a patent application for that inventor.